Eisai
4523.T
#2183
Rank
S$10.99 B
Marketcap
S$38.97
Share price
0.36%
Change (1 day)
-0.61%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.12. an increase over its 2024 EPS that were of S$1.26.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.4111.85%
2024S$1.26-32.63%
2023S$1.885.52%
2022S$1.78-74.01%
2021S$6.84-66.58%
2020S$20.4798.24%
2019S$10.3317.01%
2018S$8.8237.78%
2017S$6.40-27.62%
2016S$8.8535.33%
2015S$6.54-2.82%
2014S$6.73-27.66%
2013S$9.30-27.49%
2012S$12.83-12.67%
2011S$14.6988.08%
2010S$7.81-11.06%
2009S$8.78-390.15%
2008S-$3.03-127.78%
2007S$10.9011.78%
2006S$9.754.38%
2005S$9.347.4%
2004S$8.7043.03%
2003S$6.0825.09%
2002S$4.8652.67%
2001S$3.1869.76%
2000S$1.88